We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 17

Balancing State and Federal Informed Consent Law
  • Epstein Becker Green
  • USA
  • October 5 2017

The passage of the 21st Century Cures Act ("Cures Act") and revisions to the Common Rule (45 CFR Part 46) ("Common Rule") in the last year mandated


Protecting the privacy of scientists & physicians
  • Epstein Becker Green
  • USA
  • September 23 2010

When a scientist or physician signs on as a litigation expert, he opens himself up to scrutiny, not only about the bases for his opinion but also, to the extent permitted by law, his personal biases and professional background.


PPACA amends Rehabilitation Act to mandate standards for medical diagnostic equipment to accommodate individuals with disabilities
  • Epstein Becker Green
  • USA
  • June 9 2010

The Patient Protection and Affordable Care Act ("PPACA") contains a provision that will significantly affect all types of health care manufacturers and providers.


NY Governor Paterson introduces bill related to interactions between ‘pharmaceutical companies' and health care professionals
  • Epstein Becker Green
  • USA
  • January 29 2010

On January 19, 2010, New York Governor David Paterson introduced Senate Bill 6608 as part of the 2010-11 New York State Executive Budget.


The case for regulating laboratory-developed tests
  • Epstein Becker Green
  • USA
  • December 1 2009

For years, the IVD industry, clinical laboratories, and patient groups have debated the appropriate regulatory scheme for laboratory-developed tests (LDTs).


Wendy C. Goldstein
  • Epstein Becker Green

Sarah K. Giesting
  • Epstein Becker Green

Daniel Kim
  • Epstein Becker Green

Shilpa Prem
  • Epstein Becker Green

Gail H. Javitt
  • Epstein Becker Green